Treatment with Zogenix‘s Fintepla (ZX008) provides a sustained and meaningful reduction in convulsive seizure frequency in young children…
Articles by Alice Melao
Zygel (ZYN002) — a cannabis-based gel formulation developed by Zynerba Pharmaceuticals — can significantly reduce seizures by up…
Planning for a Phase 1 clinical trial to explore the safety and tolerability of escalating doses of EPX-100, a…
Severe epilepsy in children with Dravet and Lennox-Gastaut syndrome can be safely treated with a medicinal cannabis oil that includes,…
Inhibition of an enzyme in the “powerhouses” of cells from the hippocampus can prevent seizures in mice with intractable…
Dravet syndrome is associated with a high prevalence of behavioral problems that can severely affect quality of life, compared…
A single dose of Stoke Therapeutics’ antisense oligonucleotide, targeting the SCN1A gene, largely eliminated the incidence of seizures…
Nighttime sleep quality is poorer in Dravet syndrome patients and daytime sleepiness more pressing than patients with other types of…
The Department of Justice and the U.S. Drug Enforcement Administration (DEA) have cleared the use of the medicine Epidiolex…
Stoke Therapeutics’ targeted-augmentation of nuclear gene output (TANGO) technology effectively increased the levels of the SCN1A gene and of its…